ABEO R&D to Revenue
Abeona Therapeutics Inc · R&D to Revenue
ABEO R&D to Revenue
Latest reported460.69%period ending
ABEO FY R&D/Revenue (42.55% → 460.69%)
Latest values, visible window
High-resolution chart · PNG
ABEO r&d to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 460.6873% | |
| 0% | |
| 888.3143% | |
| 2,048.4441% | |
| 1,290.8667% | |
| 301.39% | |
| 0% | |
| 1,290.7939% | |
| 2,029.7491% | |
| 1,198.5377% | |
| 453.3654% | |
| 36% | |
| 43.2909% | |
| 45.6403% | |
| 193.6688% | |
| 696.2578% | |
| 754.8295% | |
| 4,334.3643% | |
| 4,564.9123% | |
| 0% | |
| 0% | |
| 425.3188% | |
| 196.834% | |
| 612.3801% | |
| 1,717.6955% | |
| 3,744.8598% | |
| 10,720% | |
| 1,800% | |
| 559.3103% | |
| 841.3174% | |
| 42.5467% |